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Site-speciﬁc conjugation of antifreeze proteins
onto polymer-stabilized nanoparticles†
Laura E. Wilkins,a Muhammad Hasan,a Alice E. R. Fayter, a Caroline Biggs,a
Marc Walkerb and Matthew I. Gibson *a,c
Antifreeze proteins (AFPs) have many potential applications,
ranging from cryobiology to aerospace, if they can be incorporated
into materials. Here, a range of engineered AFP mutants were pre-
pared and site-speciﬁcally conjugated onto RAFT polymer-stabil-
ized gold nanoparticles to generate new hybrid multivalent ice
growth inhibitors. Only the SNAP-tagged AFPs lead to potent ‘anti-
freeze’ active nanomaterials with His-Tag capture resulting in no
activity, showing the mode of conjugation is essential. This versa-
tile strategy will enable the development of multivalent AFPs for
translational and fundamental studies.
Antifreeze (glyco)proteins (AF(G)Ps), are found in a diverse
range of organisms1 including polar fish,2 insects3 and
plants,4 as well as ice-binding polysaccharides in insects.5
There is significant interest in the use of these proteins for low
temperature applications from aeronautical engineering to
wind turbines and for the cryopreservation of donor cells and
tissues.6,7 For this to be a reality, the AFPs need scalable synth-
eses (or mimics8,9) and methods to incorporate them into
more complex devices or coatings.10,11 AFPs have three main
eﬀects, of ice recrystallisation (growth) inhibition (IRI), non-
colligative depression of the freezing point leading to a
thermal hysteresis (TH) gap and dynamic ice shaping (DIS). To
enable interaction with the dynamic surface of ice, most AFPs
(but not the more flexible antifreeze glycoproteins12) have a
defined ice-binding face1 which can anchor them directly or
via ordered clathrate water.13–16 A distinct class of AFPs are the
hyperactive AFPs.17,18 The increased TH activity of hyperactive
AFPs is linked to their binding of both prism and basal planes
of ice, compared to just the prism plane for standard
AFPs.19,20 Increasing the concentration of particular type I
AFPs has been observed to lead to oligomerization to a tetra-
mer and the onset of hyperactivity, linked to its supramolecu-
lar assembly.21 Davies and coworkers assembled 6–11-mers of
AFP type III on PAMAM dendrimers to mimic this oligomeriza-
tion. On a per-protein basis there was only a small increase in
IRI, but the ability to span multiple ice faces increased the TH
activity.22 Synthetic mimics of AFPs also show strong mole-
cular weight dependence on activity, with longer polymers
(such as poly(vinyl alcohol) having significantly higher IRI
activity23–25 as do supramolecular safranine-O based mimics.26
Despite the evidence for increasing the valency of AFPs to
modulate activity there remain few reports of multivalent
display, in part due to the challenges of site-specific protein
conjugation.10,27,28 Traditional approaches to combine poly-
mers with proteins involve targeting unpaired cystine resi-
dues.29,30 Unnatural amino acids for bioconjugation can be
incorporated in a site-specific fashion by the AMBER stop
codon.31 Johnsson and co-workers have developed recombi-
nantly expressible ‘SNAP-tags’ based on O6alkylguanine-DNA
alkyltransferase.32 By attaching the tag as a fusion protein a
covalent bond can be formed to any surface bearing benzylgua-
nine without any unnatural amino acids. The commonly used
hexa-histidine purification tag can also facilitate ionic-
conjugation.33
Here AFPs are conjugated, by site-specific methods, onto
nanoparticles to generate hybrid ice growth inhibiting
materials to mimic the multivalent presentation of hyperactive
antifreeze proteins and aid the application of these exciting
proteins (Fig. 1).
RAFT (reversible addition fragmentation chain transfer)
polymerization was employed to synthesize telechelic poly
(hydroxyethyl acrylamide), pHEA, bearing a pentafluorophenyl
(PFP) ester at the α-terminus and a trithiocarbonate at the
ω-terminus.34 These polymers were characterized by SEC, 1H,
19F NMR and IR (Table 1). The PFP group was substituted by
addition of amino-benzylguanine (BG) (for SNAP conju-
gation32) or tris-NTA amine (for His-Tag capture). Successful
conjugation was confirmed by 19F NMR (Fig. 2B) as well as by
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IR. By using an excess of the amine, the RAFT agent end group
was displaced to reveal a thiol for gold particle conjugation. It
was also attempted to introduce a maleimide onto the par-
ticles, but this did not lead to stable particles (see ESI† for
details) so was not taken further.
4 nm citrate-stabilized gold nanoparticles (AuNP) were syn-
thesized by NaBH4 reduction of HAuCl4 and subsequently
functionalized with thiol-terminated polymers by mixing, fol-
lowed by centrifugal dialysis.35 The nanoparticles were charac-
terized by transmission electron microscopy (Fig. 3A–C),
dynamic light scattering (Fig. 3E) and UV-Vis confirming suc-
cessful addition of the polymer. X-Ray photo electron spec-
troscopy (XPS) showed a clear increase in the nitrogen N 1s
signal following coating (Fig. 3D). Screening experiments
showed that NTA-pHEA gave more stable particles when Mn =
3000 g mol−1 and for BG-pHEA = 10 000 g mol−1 and hence
these chain lengths were used from this point onwards.
Recombinant AFP type III (from ocean pout) were produced
by expression in Escherichia coli, and purified by nickel aﬃnity
chromatography and HPLC. Three mutants were produced
bearing N-terminal modifications of hexa-histidine (His-AFP),
SNAP (SNAP-AFP) and cysteine (Cys-AFP). Direct conjugation of
the SNAP-AFP was achieved by incubation with the BG-
pHEA45@AuNP4 in buﬀer. NTA-pHEA17@AuNP4 was first acti-
vated by addition of NiCl2 followed by His-AFP. Direct Cys-AFP
immobilization onto AuNPs was unsuccessful (see ESI†).
Particles were further purified by centrifugal dialyses and
removal of non-conjugated residual protein confirmed by
nanodrop absorption analysis on residual washings. Following
Fig. 1 Synthesis of gold/polymer/antifreeze protein hybrid particles. NTA = Nitrilotriacetic acid; BG = O6-benzylguanine; His6 = hexa-histidine tag.
Red ‘wrench’ represents the SNAP-tag.
Table 1 Precursor polymers synthesized
Polymer [M]/[CTA] (−) Conv.a (%) DPn (−) Mn(THEO) a (g mol−1) Mn(SEC) b (g mol−1) Đb (−)
PFP-pHEA95 103 93 95 11 000 15 000 1.3
PFP-pHEA45 47 94 45 5700 8300 1.1
PFP-pHEA17 26 64 17 2500 3000 1.1
aDetermined by 1H NMR. bDetermined by SEC against PMMA standards.
Fig. 2 (A) SEC analysis of PFP-pHEAs; (B) 19F-NMR analysis of end
group displacement.
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conjugation the zeta-potential became less negative and XPS
confirmed a further increase in the nitrogen concentration
upon protein conjugation (Table 2).
With these site-specifically attached AFP/nanoparticle con-
jugates to hand, their IRI activity could be assessed by the
‘splat’ assay. In brief, a polynucleated wafer of ice crystals is
seeded from a solution containing the compounds of interest
and the ice crystals annealed at−8 °C for 30 minutes. After this
time the average ice crystal size is evaluated and compared to a
negative control of buﬀer alone: smaller ice crystal sizes
signify more IRI activity. The two AFP mutants were very
potent inhibitors, preventing all growth below 0.01 mg mL−1.
There was no significant diﬀerence between the two mutants,
showing the fusions were tolerated in terms of retention of
function. His-AFP-Ni-NTA-pHEA17@Au4 was found to be sur-
prisingly inactive as an ice growth inhibitor with no activity up
to 1 mg mL−1 (AFP concentration). This could be due to the
dynamic nature of the His-NTA interaction or incorrect orien-
tation of the AFP on the surface. This also shows that design-
ing a multivalent AFP is non-trivial, with the correct chemistry
being essential. Previous studies suggest excess charge does
not aﬀect AFP activity and was ruled out as the cause.36 In con-
trast, the covalent hybrid nanoparticle SNAP-AFP-BG-
pHEA45@Au4 was found to be a very potent IRI, Fig. 4B. In
terms of total AFP concentration (to enable multivalent eﬀects
to be seen) the nanoparticles essentially identical activity com-
pared to SNAP-AFP alone. If considered on a molar basis (as
has been done by Davies et al. for dendrimer AFPs22) then the
particles are more active. AFPs are known to become hyperac-
tive when they oligomerize, but such enhancement was not
seen here due to the diﬀerent 3-D placement of the AFPs.21
Using a nanoliter osmometer the thermal hysteresis (TH) gap
(non-colligative freezing point depression) was determined.
TH is closely linked to the ability to bind specific ice faces (in
this case the prism plane) hence providing additional infor-
mation about the functionality of the particles; the TH is
unique to antifreeze proteins, and is defined as the diﬀerence
between the freezing and melting points. It was observed that
the AFP and SNAP-AFP nanoparticles have very similar TH
gaps, of 1.4 °C at 7.6 mg mL−1. As with the IRI measurements,
this confirms that all activity is retained despite the major
structural modifications and that the placement of the AFPs
via-polymeric linkers is tolerated. As the eﬀective AFP concen-
tration in solution when immobilized on NPs is lower, this
suggests that the particles can bind multiple planes of ice sim-
ultaneously. To probe this dynamic ice shaping experiments
were conducted in sucrose solution (as described previously28).
Compared to SNAP-AFP alone (Fig. 4H), the SNAP–AuNP conju-










Citrate@Au4 4.3 3.9 ± 0.7 −19.4 ± 2.7
NTA-pHEA17@Au4 8.5 3.7 ± 0.8 −15.9 ± 4.8
Ni-NTA-pHEA17@Au4 7.7 3.9 ± 0.8 −6.16 ± 1.1
His-AFP-Ni-NTA-pHEA17@Au4 8.9 4.3 ± 0.9 −7.03 ± 1.3
BG-pHEA45@Au4 16.5 3.9 ± 1.0 −10.2 ± 1.9
SNAP-AFP-BG-pHEA45@Au4 8.92 4.0 ± 1.1 −4.35 ± 0.9
aHydrodynamic diameter from DLS. bGold core diameter, average of
>100 particles by TEM.
Fig. 3 Nanoparticle characterization. (A–C) Transmission electron
micrographs of citrate@Au4, SNAP-AFP-BG-pHEA45@Au4 and His-
AFP-Ni-NTA-pHEA17@Au4 respectively; (D) N 1s peak from XPS upon
conjugation of SNAP-AFP; (E) diameter from dynamic light scattering.
Fig. 4 (A, C, D) IRI activity of His-AFP and conjugates by MLGS (mean
length grain size); (B, E, F) IRI activity of SNAP-AFP and conjugates; (G)
thermal hysteresis showing freezing point depression in SNAP-AFP and
conjugate samples; ice crystal morphology of (H) SNAP-AFP; (I)
SNAP-AFP-BG-pHEA45@Au4. Scale bar = 100 μm.
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gates resulted in more faceting of the ice crystals, consistent
with them being able to bind more ice faces simultaneously.22
Conclusions
In conclusion, we report the synthesis of hybrid nanoparticle–
AFP conjugates, making use of polymer-stabilized gold nano-
particles and protein engineering to enable precision-conju-
gation. Hetero-telechelic polymers were obtained by RAFT,
enabling a nanoparticle immobilization moiety (thiol) and
distal protein capture (nickel NTA or O6-benzyl-guanine)
moiety to be installed. The polymer coating is essential to
enable conjugation in buﬀer, avoiding nanoparticle aggrega-
tion. It was found that the SNAP-tag (covalent) approach lead
to the most active particles compared to oligohistidine
capture. The observed ice recrystallisation inhibition and
thermal hysteresis activity was comparable to free antifreeze
proteins on a valency-corrected basis confirming retention of
activity in this format. Other conjugation methods based on
ionic interactions did not give stable particles or resulted in
loss of activity. These results demonstrate that antifreeze
protein can be incorporated into more complex assemblies to
facilitate their application in colloid science or for fundamen-
tal studies exploiting nanoparticle cores for bioimaging and
tracking.
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